Eubiotics

Eubiotics Market Outlook

The eubiotics market is experiencing significant growth, projected to reach USD 5.8 billion by 2028, with a compound annual growth rate (CAGR) of 7.4% during the forecast period from 2021 to 2028. This growth is primarily driven by the increasing demand for natural feed additives in the livestock sector, fueled by the rising consumer awareness regarding animal health and welfare. Additionally, the growing adoption of eubiotics in various applications, including food and beverages, pharmaceuticals, and agriculture, is contributing to market expansion. A shift toward preventive healthcare and a focus on sustainable farming practices are also expected to bolster the demand for eubiotics, as these products are recognized for their ability to promote gut health and improve overall immunity in livestock.

Growth Factor of the Market

One of the primary growth factors for the eubiotics market is the rising awareness among consumers about the health benefits associated with natural and organic products. As more individuals prioritize health and nutrition, the demand for eubiotic solutions in animal feed and human consumption is on the rise. Furthermore, regulatory bodies are increasingly advocating for the reduction of antibiotic usage in livestock, which is driving farmers and producers to seek alternatives such as eubiotics. The evolution of the food and beverage industry is also contributing to market growth as manufacturers seek to enhance product quality and shelf-life through the incorporation of probiotics and prebiotics. Additionally, advancements in research and development are leading to innovative product formulations and applications, making eubiotics more appealing to a broader range of consumers. The global push for sustainability and eco-friendly practices is another significant factor, as eubiotics support the reduction of chemical additives in food production.

Key Highlights of the Market

• The demand for probiotics is steadily increasing due to their well-established health benefits.
• North America is anticipated to hold a significant market share, driven by rising livestock production.
• Probiotics are expected to dominate the product type segment.
• The feed application segment is experiencing rapid growth, bolstered by the rising livestock rearing practices.
• The liquid form of eubiotics is gaining traction due to its ease of application and effectiveness.

By Product Type

Probiotics:

Probiotics are among the most popular eubiotic products, recognized for their ability to enhance gut flora and improve digestive health. They are live microorganisms that confer health benefits when consumed in adequate amounts, primarily found in fermented foods and supplements. In the eubiotics market, probiotics are widely used in animal feed to promote gut health, enhance nutrient absorption, and boost immunity. The increasing awareness of the adverse effects of antibiotics in livestock production is driving the demand for probiotics, as they serve as a natural alternative to promote animal health and growth. Moreover, the expansion of research supporting the efficacy of probiotics in improving livestock performance is further enhancing their adoption in various applications.

Prebiotics:

Prebiotics are non-digestible food ingredients that stimulate the growth and activity of beneficial microorganisms in the gut. They play a crucial role in enhancing gut health and promoting the overall well-being of animals. In the eubiotics market, prebiotics are increasingly being used as feed additives to improve digestion and nutrient utilization in livestock. The rising awareness among livestock producers about the benefits of prebiotics in enhancing animal performance and health is driving their demand. Additionally, the growing prevalence of gastrointestinal disorders in animals has fueled the need for prebiotic solutions, leading to their expanded usage across various livestock sectors.

Synbiotics:

Synbiotics are formulations that combine both probiotics and prebiotics, designed to synergistically improve gut health and enhance the overall efficacy of the product. These products are increasingly gaining traction in the eubiotics market due to their dual action in promoting the growth of beneficial gut bacteria while providing nutrients that support their activity. The demand for synbiotics is on the rise as consumers and livestock producers recognize the comprehensive health benefits associated with these products. The ability of synbiotics to enhance digestion, improve nutrient absorption, and support the immune system makes them highly appealing, thereby driving their adoption in various applications, including animal feed.

Organic Acids:

Organic acids are another critical product type within the eubiotics market, known for their antimicrobial properties that help control harmful bacteria in the gut. These acids, such as acetic acid and lactic acid, play a vital role in enhancing gut health and improving feed efficiency in livestock. The growing focus on maintaining animal health without relying on antibiotics is propelling the demand for organic acids as a natural alternative. They can effectively lower the pH of the gut, creating an environment conducive to beneficial microorganisms while inhibiting pathogens. As livestock producers increasingly seek sustainable and natural solutions for animal health management, organic acids are becoming a vital component of eubiotic formulations.

Essential Oils:

Essential oils have gained attention in the eubiotics market due to their multifaceted benefits in promoting animal health and wellness. These natural plant extracts are known for their antimicrobial, anti-inflammatory, and antioxidant properties, making them effective in enhancing gut health and overall performance in livestock. Essential oils can also improve feed palatability, leading to better feed intake and nutrient absorption. The rising trend towards natural and organic farming practices is driving the demand for essential oils, as producers seek to avoid synthetic additives in animal feed. Additionally, research supporting the efficacy of essential oils in controlling pathogens and improving animal welfare is further propelling their adoption within the industry.

By Application

Feed:

The feed application segment is a significant driver of the eubiotics market, as these products are increasingly incorporated into animal feed formulations to enhance health and performance. Eubiotics play a vital role in improving digestion, boosting immunity, and promoting gut health in livestock, which is crucial for achieving optimal growth and productivity. As concerns about antibiotic resistance grow, livestock producers are actively seeking alternatives such as eubiotics to maintain animal health and performance. The application of eubiotics in feed is expected to continue growing, driven by the increasing demand for sustainable and natural solutions in animal agriculture, as well as the expansion of livestock production globally.

Food & Beverages:

In the food and beverages sector, eubiotics are gaining popularity due to their health benefits, particularly in improving gut health and immunity. Consumers are becoming more health-conscious and are looking for products that contain probiotics and prebiotics to support their digestive health. The incorporation of eubiotics into functional foods and beverages, such as yogurts, dairy products, and health drinks, is on the rise, as manufacturers aim to meet consumer demands for products that promote wellness. The growing trend of health and wellness, along with the increasing popularity of fermented foods, is expected to drive the eubiotics market in the food and beverages application segment.

Pharmaceuticals:

The pharmaceuticals application segment is witnessing an upward trend in the use of eubiotics, primarily due to their therapeutic properties. Eubiotics, especially probiotics, are being researched and developed for their potential health benefits, including the treatment and prevention of gastrointestinal disorders, infections, and other health conditions. The increasing focus on preventive healthcare and the demand for natural remedies are driving the incorporation of eubiotics into pharmaceutical formulations. As more clinical studies validate the effectiveness of eubiotics in improving health outcomes, their adoption in the pharmaceutical sector is expected to expand, contributing to the overall growth of the eubiotics market.

By Livestock

Poultry:

The poultry segment is a key contributor to the eubiotics market, as these products are extensively used in chicken and turkey production to enhance growth performance and health. The increasing consumer demand for poultry products, combined with the necessity of maintaining animal health and welfare, is driving the adoption of eubiotics in this sector. Poultry producers are increasingly turning to probiotics, prebiotics, and organic acids to improve gut health, enhance feed efficiency, and reduce the incidence of diseases. The rise in intensive poultry farming techniques is also propelling the demand for eubiotic solutions, as farmers seek sustainable practices to ensure the overall well-being of their flocks.

Swine:

The swine segment is witnessing significant growth in the utilization of eubiotics, as these products are essential for promoting health and performance in pigs. Eubiotics are increasingly being incorporated into swine diets to improve gut health, enhance nutrient digestion, and support the immune system, thereby leading to better weight gain and feed conversion ratios. The growing awareness of the negative effects of antibiotics on livestock health and food safety is driving pig producers to adopt eubiotic solutions as a natural alternative. Moreover, as the global demand for pork continues to rise, the inclusion of eubiotics in swine production is expected to become more prevalent, contributing to market growth.

Ruminants:

The ruminants segment, which includes cattle and sheep, is an important market for eubiotics due to the unique digestive systems of these animals. Eubiotics play a crucial role in enhancing rumen health by promoting the growth of beneficial microorganisms and improving nutrient absorption. The increasing focus on animal welfare and sustainable farming practices is driving ruminant producers to adopt eubiotic solutions as part of their feeding strategies. Additionally, the rising demand for dairy and beef products globally is fueling the need for effective solutions to enhance livestock productivity, leading to an increased incorporation of eubiotics in ruminant diets.

Aquaculture:

The aquaculture segment is emerging as a significant market for eubiotics, as the use of these products can enhance the health and growth of aquatic animals. Eubiotics are increasingly utilized in fish and shrimp farming to improve gut health, boost immunity, and reduce the reliance on antibiotics. The growing global demand for seafood, coupled with the challenges of maintaining fish health in intensive farming systems, is driving the adoption of eubiotics in aquaculture. As concerns regarding food safety and sustainability in seafood production rise, the integration of eubiotics is expected to play a crucial role in promoting healthier aquatic environments and enhancing productivity in the aquaculture sector.

By Form

Liquid:

The liquid form of eubiotics is gaining popularity in the market due to its ease of application and effectiveness. Liquid eubiotics can be easily mixed with feed or water, making them convenient for livestock producers. This form allows for better absorption and quicker results in terms of health benefits, particularly in improving gut health and enhancing nutrient utilization. The growing trend toward liquid probiotics and prebiotics in both livestock and human consumption is driving the demand for this form of eubiotics. Moreover, the versatility of liquid formulations enables them to be incorporated into various products, further expanding their market presence.

Dry:

The dry form of eubiotics, including powders and granules, is also widely used in the market due to its stability and longer shelf life. Dry eubiotics are easy to store and transport, making them a preferred choice for many livestock producers. They can be easily integrated into feed formulations, ensuring accurate dosing and even distribution. The demand for dry eubiotics is particularly strong in large-scale livestock operations, where consistency and convenience are crucial. As the market for eubiotics continues to expand, the dry form is expected to maintain a significant share, catering to the needs of various livestock sectors.

By Region

The eubiotics market is experiencing robust growth across various regions, with North America leading in market share due to the high demand for animal feed additives and a significant livestock industry. This region is projected to witness a CAGR of 6.9% from 2021 to 2028, driven by the increasing focus on animal health and the rising prevalence of antibiotic alternatives. The growing awareness among consumers regarding natural and organic products is also contributing to the expansion of the eubiotics market in North America. Additionally, the presence of major players and strong research and development activities in this region are further facilitating market growth.

Europe is another prominent region in the eubiotics market, characterized by strict regulations regarding animal health and welfare. The increasing adoption of sustainable farming practices and the rising demand for high-quality animal products are driving the growth of eubiotics in this region. With a significant rise in the production of poultry, swine, and ruminants, the demand for eubiotic solutions is projected to increase in Europe. The Asia Pacific region is also expected to witness substantial growth, fueled by the burgeoning livestock industry and the rising awareness of the health benefits of eubiotics. This region's growing population and the subsequent demand for animal protein are propelling the adoption of eubiotics in livestock production.

Opportunities

The growing trend towards natural and organic farming practices presents significant opportunities for the eubiotics market. As consumers become more health-conscious and demand safer, chemical-free food products, livestock producers are increasingly seeking alternatives to synthetic additives. Eubiotics, being natural and beneficial for gut health, are well-positioned to fill this gap. With regulatory bodies emphasizing the reduction of antibiotics in livestock production, the market for eubiotics is poised to expand as they provide a viable solution for maintaining animal health without compromising food safety. Furthermore, the increasing research and development in the field of microbiome science offer opportunities for innovation in eubiotic formulations, potentially leading to more effective products that cater to specific health needs in livestock.

Another notable opportunity lies within the growing aquaculture sector, where the demand for sustainable and effective health management solutions is rising. Eubiotics offer a promising avenue for aquaculture producers looking to enhance fish and shrimp health while reducing antibiotic use. As the global demand for seafood continues to escalate, the incorporation of eubiotics into aquaculture diets can help ensure healthier aquatic environments and improve production efficiency. Additionally, the expanding market for functional foods and beverages presents opportunities for eubiotic products aimed at human consumption, as consumers increasingly seek products that promote gut health and overall wellness. This dual focus on livestock and human health provides a unique pathway for growth in the eubiotics market.

Threats

Despite the numerous growth opportunities, the eubiotics market faces several potential threats that could hinder its expansion. One major concern is the regulatory landscape surrounding eubiotic products, which can vary significantly across regions. Stringent regulations concerning the safety and efficacy of these products may create barriers to entry for new players and hinder innovation within the market. Additionally, the market is highly competitive, with numerous established players vying for market share. This intense competition can lead to price wars, reducing profit margins for manufacturers and potentially impacting product quality. Furthermore, the fluctuating prices of raw materials used in the production of eubiotics can also pose a threat, as it may affect pricing strategies and overall profitability.

Moreover, consumer skepticism regarding the efficacy of eubiotic products can pose a challenge for market growth. While awareness of gut health and the benefits of eubiotics is increasing, some consumers may remain hesitant to adopt these products due to lack of familiarity or understanding. Effective marketing and educational initiatives are crucial to overcoming this hurdle and promoting the value of eubiotics. Lastly, potential adverse effects associated with the overuse of eubiotic products could lead to negative publicity and regulatory scrutiny, further complicating the market landscape. It is essential for manufacturers to prioritize research and quality assurance to mitigate these threats and maintain consumer trust.

Competitor Outlook

• Chr. Hansen Holdings A/S
• DuPont de Nemours, Inc.
• Evonik Industries AG
• Novozymes A/S
• Kemin Industries, Inc.
• Synlogic, Inc.
• ProbioFerm
• Bifodan A/S
• BASF SE
• BioCare Copenhagen A/S
• Probi AB
• Eligo Bioscience
• Lallemand Inc.
• Naturex S.A.
• Adisseo France SAS

The competitive landscape of the eubiotics market is characterized by a mix of established players and emerging companies striving to capitalize on the growing demand for natural and effective health solutions in both livestock and human applications. Leading companies such as Chr. Hansen and DuPont are at the forefront of innovation, investing heavily in research and development to create advanced eubiotic formulations. These established players benefit from strong brand recognition, extensive distribution networks, and partnerships with key stakeholders in the agriculture and food industries. Their focus on sustainability and compliance with regulatory requirements positions them favorably in an increasingly competitive market.

As the market evolves, smaller companies are also making their mark by offering niche eubiotic products that cater to specific consumer needs. For example, companies like Probi AB and Bifodan A/S are focusing on developing tailored probiotics and prebiotics for different livestock species, thus providing differentiated products that can attract targeted customer segments. Furthermore, the growing trend of collaborations and partnerships among companies is fostering innovation and expanding market reach. Companies are increasingly joining forces with research institutions and universities to enhance their product offerings and tap into new markets.

In terms of key players, Evonik Industries AG stands out with its comprehensive portfolio of eubiotic solutions tailored for both animal nutrition and human health. The company has established a reputation for quality and reliability, making it a trusted partner in the livestock sector. Kemin Industries is another notable player, known for its commitment to sustainability and customer-focused solutions. With a diverse range of eubiotic products, Kemin is well-equipped to meet the evolving demands of the market. Additionally, Novozymes is leveraging its expertise in enzyme technology to develop innovative eubiotic formulations that enhance animal performance while promoting environmental sustainability.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Probi AB
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ProbioFerm
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Bifodan A/S
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Naturex S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Novozymes A/S
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Lallemand Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Synlogic, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Eligo Bioscience
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Adisseo France SAS
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Evonik Industries AG
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 BioCare Copenhagen A/S
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Kemin Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 DuPont de Nemours, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Chr. Hansen Holdings A/S
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Eubiotics Market, By Form
    • 6.1.1 Liquid
    • 6.1.2 Dry
  • 6.2 Eubiotics Market, By Livestock
    • 6.2.1 Poultry
    • 6.2.2 Swine
    • 6.2.3 Ruminants
    • 6.2.4 Aquaculture
  • 6.3 Eubiotics Market, By Application
    • 6.3.1 Feed
    • 6.3.2 Food & Beverages
    • 6.3.3 Pharmaceuticals
  • 6.4 Eubiotics Market, By Product Type
    • 6.4.1 Probiotics
    • 6.4.2 Prebiotics
    • 6.4.3 Synbiotics
    • 6.4.4 Organic Acids
    • 6.4.5 Essential Oils

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Eubiotics Market by Region
  • 10.3 Asia Pacific - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 India
      • 10.3.1.2 China
      • 10.3.1.3 Japan
      • 10.3.1.4 South Korea
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Eubiotics market is categorized based on

By Product Type

• Probiotics
• Prebiotics
• Synbiotics
• Organic Acids
• Essential Oils

By Application

• Feed
• Food & Beverages
• Pharmaceuticals

By Livestock

• Poultry
• Swine
• Ruminants
• Aquaculture

By Form

• Liquid
• Dry

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Chr. Hansen Holdings A/S
• DuPont de Nemours, Inc.
• Evonik Industries AG
• Novozymes A/S
• Kemin Industries, Inc.
• Synlogic, Inc.
• ProbioFerm
• Bifodan A/S
• BASF SE
• BioCare Copenhagen A/S
• Probi AB
• Eligo Bioscience
• Lallemand Inc.
• Naturex S.A.
• Adisseo France SAS